USP14-mediated IκBα degradation exacerbates NF-κB activation and IL-1β-stimulated chondrocyte dedifferentiation
Authors:
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 218, 147-152
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Overexpression of USP14 Protease Reduces I-κB Protein Levels and Increases Cytokine Release in Lung Epithelial CellsJournal of Biological Chemistry, 2013
- Hierarchies of NF-κB target-gene regulationNature Immunology, 2011
- Balancing act: deubiquitinating enzymes in the nervous systemTrends in Neurosciences, 2011
- Inhibiting NF-κB activation by small molecules as a therapeutic strategyBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 2010
- Enhancement of proteasome activity by a small-molecule inhibitor of USP14Nature, 2010
- The IKK‐NF‐κB pathway: a source for novel molecular drug targets in pain therapy?The FASEB Journal, 2008
- Major biological obstacles for persistent cell-based regeneration of articular cartilageArthritis Research & Therapy, 2007
- Introduction to NF-κB: players, pathways, perspectivesOncogene, 2006
- c-Jun/Activator Protein-1 Mediates Interleukin-1β-induced Dedifferentiation but Not Cyclooxygenase-2 Expression in Articular ChondrocytesJournal of Biological Chemistry, 2005
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986